Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID02915198

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular Outcomes (VA-IMPACT)

Led by VA Office of Research and Development · Updated on 2025-12-17

7410

Participants Needed

40

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying whether the medicine metformin can reduce the risk of death, heart attacks, and strokes in Veterans who have pre-diabetes along with problems related to heart or blood vessels. This is a multicenter, prospective, randomized, double-blind trial focused on secondary prevention to compare metformin with placebo in reducing mortality and cardiovascular complications. Eligible participants have pre-diabetes based on blood sugar levels and established atherosclerotic cardiovascular disease, with adequate kidney function. Participants are randomly assigned to receive either metformin extended-release (XR) or a matching placebo. The treatment starts with 500 mg of metformin XR or placebo once daily, with doses gradually increased up to 2000 mg daily as tolerated. All participants also receive counseling on lifestyle changes to support their health. The study began its full-scale phase in April 2023 following a pilot phase and will continue with treatment and monitoring over several years. During the study, participants will have regular assessments including monitoring for death, heart attacks, strokes, hospitalizations for unstable angina, and coronary procedures, tracked over an average of 4.5 years. Researchers will measure time to these events as the main outcome. Secondary outcomes include cardiovascular, cancer-related, and diabetes-related events. Participants will be followed closely to ensure safety and adherence to the study medication and procedures throughout the trial period.

CONDITIONS

Brief Title

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older
  • Diagnosed with pre-diabetes based on HbA1c, fasting glucose, or oral glucose tolerance test
  • Established atherosclerotic cardiovascular disease in coronary, cerebrovascular, or peripheral arteries
  • Estimated glomerular filtration rate of at least 45 mL/min/1.73 m2
  • Ability and willingness to provide informed consent and follow study procedures
Not Eligible

You will not qualify if you...

  • Use of metformin or other anti-diabetic medications within 12 months prior to randomization
  • Treatment with systemic glucocorticoids within 3 months prior to randomization
  • Fasting plasma glucose over 130 mg/dL or HbA1c 7.0% or higher within 12 months
  • Low total CO2 below normal laboratory limits
  • Current use of cimetidine, vandetanib, or systemic carbonic anhydrase inhibitors
  • Liver problems such as cirrhosis, active hepatitis, or jaundice
  • Heavy alcohol use within 6 months
  • Severe anemia with hemoglobin less than 10 g/dL
  • History of metformin intolerance
  • Heart attack, coronary procedure, or stroke within 1 month prior to randomization
  • Uncontrolled high blood pressure
  • Acute or decompensated heart failure
  • Expected survival less than study duration
  • Inability or unwillingness to comply with study requirements
  • Dementia or cognitive impairment
  • Participation in other randomized drug or device trials
  • Pregnancy, intent to become pregnant, or breastfeeding
  • Women of childbearing potential not using highly effective contraception

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to approximately 4.5 years

Participants receive metformin XR or placebo with dose titration up to a maximum of 2000 mg daily based on safety and tolerability, along with counseling on therapeutic lifestyle recommendations.

Regular visits for medication management and safety monitoring

Trial Site Locations

Total: 40 locations

1

Phoenix VA Health Care System, Phoenix, AZ

Phoenix, Arizona, United States, 85012

Actively Recruiting

2

Southern Arizona VA Health Care System, Tucson, AZ

Tucson, Arizona, United States, 85723-0001

Actively Recruiting

3

Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR

Little Rock, Arkansas, United States, 72205-5484

Actively Recruiting

4

VA Loma Linda Healthcare System, Loma Linda, CA

Loma Linda, California, United States, 92357-1000

Actively Recruiting

5

VA Long Beach Healthcare System, Long Beach, CA

Long Beach, California, United States, 90822

Actively Recruiting

6

VA Palo Alto Health Care System, Palo Alto, CA

Palo Alto, California, United States, 94304-1207

Actively Recruiting

7

VA San Diego Healthcare System, San Diego, CA

San Diego, California, United States, 92161-0002

Actively Recruiting

8

VA Greater Los Angeles Healthcare System, West Los Angeles, CA

West Los Angeles, California, United States, 90073-1003

Actively Recruiting

9

Rocky Mountain Regional VA Medical Center, Aurora, CO

Aurora, Colorado, United States, 80045-7211

Actively Recruiting

10

VA Connecticut Healthcare System West Haven Campus, West Haven, CT

West Haven, Connecticut, United States, 06516-2770

Actively Recruiting

11

Bay Pines VA Healthcare System, Pay Pines, FL

Bay Pines, Florida, United States, 33744-0000

Actively Recruiting

12

North Florida/South Georgia Veterans Health System, Gainesville, FL

Gainesville, Florida, United States, 32608-1135

Actively Recruiting

13

Miami VA Healthcare System, Miami, FL

Miami, Florida, United States, 33125

Actively Recruiting

14

Atlanta VA Medical and Rehab Center, Decatur, GA

Decatur, Georgia, United States, 30033-4004

Actively Recruiting

15

VA Pacific Islands Health Care System, Honolulu, HI

Honolulu, Hawaii, United States, 96819-1522

Actively Recruiting

16

Jesse Brown VA Medical Center, Chicago, IL

Chicago, Illinois, United States, 60612

Terminated

17

Edward Hines Jr. VA Hospital, Hines, IL

Hines, Illinois, United States, 60141-3030

Actively Recruiting

18

Iowa City VA Health Care System, Iowa City, IA

Iowa City, Iowa, United States, 52246-2292

Actively Recruiting

19

Lexington VA Medical Center, Lexington, KY

Lexington, Kentucky, United States, 40502-2235

Not Yet Recruiting

20

Rehabilitation R&D Service, Baltimore, MD

Baltimore, Maryland, United States, 21202

Actively Recruiting

21

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Boston, Massachusetts, United States, 02130-4817

Actively Recruiting

22

Minneapolis VA Health Care System, Minneapolis, MN

Minneapolis, Minnesota, United States, 55417-2309

Actively Recruiting

23

Kansas City VA Medical Center, Kansas City, MO

Kansas City, Missouri, United States, 64128-2226

Actively Recruiting

24

Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE

Omaha, Nebraska, United States, 68105-1850

Actively Recruiting

25

New Mexico VA Health Care System, Albuquerque, NM

Albuquerque, New Mexico, United States, 87108-5153

Actively Recruiting

26

Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY

New York, New York, United States, 10010-5011

Actively Recruiting

27

Durham VA Medical Center, Durham, NC

Durham, North Carolina, United States, 27705-3875

Actively Recruiting

28

Cincinnati VA Medical Center, Cincinnati, OH

Cincinnati, Ohio, United States, 45220-2213

Active, Not Recruiting

29

Louis Stokes VA Medical Center, Cleveland, OH

Cleveland, Ohio, United States, 44106-1702

Actively Recruiting

30

VA Portland Health Care System, Portland, OR

Portland, Oregon, United States, 97207-2964

Actively Recruiting

31

Ralph H. Johnson VA Medical Center, Charleston, SC

Charleston, South Carolina, United States, 29401-5703

Actively Recruiting

32

Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC

Columbia, South Carolina, United States, 29209-1638

Actively Recruiting

33

Memphis VA Medical Center, Memphis, TN

Memphis, Tennessee, United States, 38104-2127

Actively Recruiting

34

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

Dallas, Texas, United States, 75216-7167

Actively Recruiting

35

Michael E. DeBakey VA Medical Center, Houston, TX

Houston, Texas, United States, 77030-4211

Actively Recruiting

36

VA Salt Lake City Health Care System, Salt Lake City, UT

Salt Lake City, Utah, United States, 84148-0001

Actively Recruiting

37

Hunter Holmes McGuire VA Medical Center, Richmond, VA

Richmond, Virginia, United States, 23249

Actively Recruiting

38

Salem VA Medical Center, Salem, VA

Salem, Virginia, United States, 24153-6404

Actively Recruiting

39

Huntington VA Medical Center, Huntington, WV

Huntington, West Virginia, United States, 25704-9300

Actively Recruiting

40

Clement J. Zablocki VA Medical Center, Milwaukee, WI

Milwaukee, Wisconsin, United States, 53295-0001

Actively Recruiting

Loading map...

Research Team

G

Gregory G Schwartz, PhD MD

K

Kevin Gropp

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Two-Center, Randomized, Double-Blind, Placebo-Controlled, ...

Atherosclerosis

Actively Recruiting

2 locations

A Phase IIa Multicenter Randomized Double-blind Placebo-cont...

Atherosclerosis

Actively Recruiting

6 locations

Acute Exposure to Diesel: Prolonged Effects on Inflammation ...

Atherosclerosis

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here